VBI Vaccines Inc. (VBIV)

VBI Vaccines Revenue

VBI Vaccines had revenue of $9.41M in the twelve months ending March 31, 2024, with 553.09% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.21M with 150.31% year-over-year growth. In the year 2023, VBI Vaccines had annual revenue of $8.68M with 702.40% growth.

• Revenue (ttm): $9.41M
• Revenue Growth: +553.09%
• P/S Ratio: 1.81
• Revenue / Employee: $68,196
• Employees: 138
• Market Cap: 17.06M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.68M	7.60M	702.40%
Dec 31, 2022	1.08M	451.00K	71.47%
Dec 31, 2021	631.00K	-430.00K	-40.53%
Dec 31, 2020	1.06M	-1.16M	-52.23%
Dec 31, 2019	2.22M	-1.13M	-33.80%
Dec 31, 2018	3.36M	2.49M	287.86%
Dec 31, 2017	865.00K	317.00K	57.85%
Dec 31, 2016	548.00K	-407.00K	-42.62%
Dec 31, 2015	955.00K	-1.91M	-66.70%
Dec 31, 2014	2.87M	1.21M	72.67%
Dec 31, 2013	1.66M	1.05M	172.01%
Mar 31, 2012	610.65K	568.65K	1,354.06%
Mar 31, 2011	42.00K	41.24K	5,455.03%
Mar 31, 2010	756.00	-8.36K	-91.71%
Mar 31, 2009	9.12K	-2.46K	-21.25%
Mar 31, 2008	11.58K	-2.49K	-17.71%
Mar 31, 2007	14.07K	2.61K	22.72%
Mar 31, 2006	11.47K	11.05K	2,623.52%
Mar 31, 2005	421.00	525.00	-504.81%
Mar 31, 2004	-104.00	-829.00	-114.34%
Mar 31, 2003	725.00	-86.00	-10.60%
Mar 31, 2002	811.00	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.